祝颖慧
zhuyinghui@tongji.edu.cn
中文, 英语
上海
同济大学
Life Sciences
  • 2010.9-2016.1 理学博士:中国科学院北京基因组研究所
  • 入选上海市海外高层次人才计划
  • 2023.2至今 - 同济大学附属东方医院转化医学中心;研究员
  • 2022.9至今 - 同济大学生命科学与技术学院/同济大学高等研究院;特聘研究员
  • 2016.3-2020 - 美国希望之城国家医疗中心;博士后/在职科学家
急性白血病发病及耐药机制
白血病的靶向免疫疗法开发
  • Phosphoproteomic Characterization and Kinase Signature Predict Response to Venetoclax plus 3+7 Chemotherapy in AML, Jin J, Hou SY, Yao YY, Mao LP, Yang M, Tong HY, Zeng T, Huang JY, Zhu YH, Wang HF, 2023
  • Identification of a novel NPM1 mutation in acute myeloid leukemia, Yao YY, Lin XJ, Wang C, Gu Y, Jin J, Zhu YH, Wang HF, 2023
  • CD38-directed, single-chain T cell-engager targets leukemia stem cells through IFNγ-induced CD38 expression, Murtadha M, Park M, Zhu YH, Caserta E, Napolitano O, Tandoh T, Moloudizargari M, Pozhitkov A, Singer M, Dona AA, Vahed H, Gonzalez A, Ly K, Ouyang C, Sanchez JF, Nigam L, Chowdhury A, Ghoda L, Li L, Zhang B, Krishnan A, Marcucci G, Williams JC, Pichiorri F, 2024
  • Phosphoproteomics profiling reveals a kinase network conferring acute myeloid leukaemia intrinsic chemoresistance and indicates HMGA1 phosphorylation as a potential influencer, Zhu YH, He X, Li S, Gan YC, Li Z, Wang HY, et al., and Li L, 2022
  • Targeting PRMT1-Mediated FLT3 Methylation Disrupts Maintenance of MLL- rearranged Acute Lymphoblastic Leukemia, Zhu YH, He X, Lin YC, Dong HJ, Zhang L, Chen XC, Wang ZH, Shen YD, Li M, Wang HY, Sun J, Nguyen LX, Zhang H, Jiang WJ, Yang YZ, Chen JJ, Müschen M, Chen CW, Konopleva MY, Sun WL, Jin J, Carlesso N, Marcucci G, Luo Y, and Li L, 2019
  • A Comprehensive Proteomics Analysis Reveals a Secretory Path- and Status-Dependent Signature of Exosomes Released from Tumor-Associated Macrophages, Zhu YH, Chen XW, Pan QF, Wang Y, Su SY, Jiang CC, Li Y, Xu NZ, Wu L, Lou XM, and Liu SQ, 2015
  • mTORC1 alters the expression of glycolytic genes by regulating KPNA2 abundances, Chen XW, Zhu YH, Wang ZH, Zhu HS, Pan QF, Su SY, et al., Liu SQ, 2016
  • SIRT1 Activation Disrupts Maintenance of Myelodysplastic Syndrome Stem and Progenitor Cells by Restoring TET2 Function, Sun J, He X, Zhu YH, Ding ZH, Dong HJ, Feng YM, Du J, Wang HY, Wu XW, Zhang L, Yu XC, Lin A, McDonald T, Zhao DD, Wu H, Hua WK, Zhang B, Feng LF, Tohyama K, Bhatia R, Oberdoerffer P, Chung YJ, Peter DA, Jacqueline B, Andrea P, Samer K, Marcin K, Pichiorri F, Kuo YH, Carlesso N, Guido M, Jin HC, and Li L, 2018
白血病 急性 发病机制 耐药 机制 靶向 免疫疗法 开发 临床应用 多维组学

联系我们

欢迎与我们交流!
* Required
* Required
* Required
* Invalid email address
提交此表单,即表示您同意 IoT ONE 可以与您联系并分享洞察和营销信息。
不,谢谢,我不想收到来自 IoT ONE 的任何营销电子邮件。
提交

感谢您的信息!
我们会很快与你取得联系。